We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
77 ELEKTRONIKA

Download Mobile App




Events

31 Jul 2024 - 02 Aug 2024
02 Aug 2024 - 04 Aug 2024
20 Aug 2024 - 22 Aug 2024

First-Ever Standard for Gallbladder Cancer Surgery Could Improve Patient Outcomes

By HospiMedica International staff writers
Posted on 30 May 2023
Print article
Image: The benchmark may be useful in identifying the best treatment hospital for patients with gallbladder cancer (Photo courtesy of Freepik)
Image: The benchmark may be useful in identifying the best treatment hospital for patients with gallbladder cancer (Photo courtesy of Freepik)

Gallbladder cancer (GBC) surgery is a technically demanding procedure that requires significant expertise to meet high-quality surgical standards. Despite this, subpar surgeries are common, highlighting the need for specific quality benchmarks. The quality of surgery significantly affects both immediate and long-term postoperative outcomes, and is a critical factor in studies evaluating surgical results. Benchmarking is one method for developing precise quality measures. It's a process of quality improvement where optimal outcomes are identified to serve as a reference point for comparing performance.

For the first time, researchers from Boston University School of Medicine (Boston, MA, USA) and the University of Texas MD Anderson Cancer Center (Houston, TX, USA) have established a benchmark for GBC surgery. This benchmark could help identify the best treatment hospitals for patients with gallbladder cancer and enhance the overall quality of care. The team analyzed data from over 900 patients who underwent GBC surgery between 2000 and 2021 at 13 different hospitals across seven countries and four continents. From this data, a benchmark group was chosen. This group included 245 low-risk patients who underwent standard GBC surgery at established centers of excellence, programs that are distinguished by their high levels of expertise and associated resources. This group was used as a standard for comparison.

The researchers used the benchmark group to establish best practice guidelines related to surgical outcomes, such as the duration of surgery, rates of morbidity, severe morbidity, blood loss, transfusion, positive margin, and the number of lymph nodes retrieved. When compared to the non-benchmark group, the benchmark group displayed significantly better overall survival rates. The researchers believe that the benchmark values they've established will enable surgeons and institutions to define the best possible outcomes for GBC patients and facilitate comparisons with other patient groups, thereby enhancing the quality of collaborative research.

“Defining benchmark values for GBC surgery will create a reference that institutions can use to assess their surgical performance, improve surgical outcomes and help move centers that currently perform lower-quality GBC surgery toward performing higher-quality surgery,” said corresponding author Eduardo Vega, MD, assistant professor of surgery at the School. “The use of a benchmark (best candidate for surgery) group of patients is an important factor that can help healthcare providers and patients make more informed decisions about treatment options and potential outcomes.”

Related Links:
University School of Medicine 
University of Texas MD Anderson Cancer Center 

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Gold Member
12-Channel ECG
CM1200B
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Transport Ventilator
TV80

Print article

Channels

Critical Care

view channel
Image: Peerbridge Cor is a 3-lead, 2-channel wireless AECG that simplifies the testing and diagnostic process (Photo courtesy of Peerbridge Health)

First-of-its-Kind Trial to Measure Ejection Fraction Severity Directly from AI-Enabled Remote ECG Wearable

Echocardiograms are a standard diagnostic tool to measure ejection fraction but require a clinical setting for administration. This can pose challenges such as scheduling delays, staffing shortages, accessibility... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: POCT offers cost-effective, accessible, and immediate diagnostic solutions (Photo courtesy of Flinders University)

POCT for Infectious Diseases Delivers Laboratory Equivalent Pathology Results

On-site pathology tests for infectious diseases in rural and remote locations can achieve the same level of reliability and accuracy as those conducted in hospital laboratories, a recent study suggests.... Read more

Business

view channel
Image: The Innovalve transseptal delivery system is designed to enable safe deployment of the Innovalve implant (Photo courtesy of Innovalve Bio)

Edwards Lifesciences Acquires Sheba Medical’s Innovalve Bio Medical

Edwards Lifesciences (Irvine, CA, USA), a leading company in medical innovations for structural heart disease and critical care, has acquired Innovalve Bio Medical LTD. (Ramat Gan, Israel), an early-stage... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.